Correlation Between Inozyme Pharma and Erasca

Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Erasca at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Erasca into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Inozyme Pharma and Erasca Inc, you can compare the effects of market volatilities on Inozyme Pharma and Erasca and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Erasca. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Erasca.

Diversification Opportunities for Inozyme Pharma and Erasca

-0.25

Correlation Coefficient

Inozyme Pharma  Erasca

Very good diversification

The 3 months correlation between Inozyme and Erasca is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and Erasca Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Erasca Inc and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Erasca. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Erasca Inc has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Erasca go up and down completely randomly.

Pair Corralation between Inozyme Pharma and Erasca

Given the investment horizon of 90 days Inozyme Pharma is expected to under-perform the Erasca. But the stock apears to be less risky and, when comparing its historical volatility, Inozyme Pharma is 1.14 times less risky than Erasca. The stock trades about 0.0 of its potential returns per unit of risk. The Erasca Inc is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  225.00  in Erasca Inc on September 14, 2024 and sell it today you would earn a total of  34.00  from holding Erasca Inc or generate 15.11% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Inozyme Pharma  vs.  Erasca Inc

Inozyme Pharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Inozyme Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Erasca Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Erasca Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Erasca is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Inozyme Pharma and Erasca

The main advantage of trading using opposite Inozyme Pharma and Erasca positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Erasca can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Erasca will offset losses from the drop in Erasca's long position.

The idea behind Inozyme Pharma and Erasca Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..